Dexcom Inc Stock Market Value
| DXCM Stock | USD 78.10 0.16 0.21% |
| Symbol | DexCom |
DexCom Inc Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.157 | Earnings Share 1.66 | Revenue Per Share 10.089 | Quarterly Revenue Growth 0.02 | Return On Assets 0.0606 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in DexCom on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 30 days. DexCom is related to or competes with Tandem Diabetes, Inspire Medical, Penumbra, Insulet, Integra LifeSciences, Senseonics Holdings, and Edwards Lifesciences. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.61 | |||
| Information Ratio | 0.0067 | |||
| Maximum Drawdown | 8.17 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 4.17 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.0575 | |||
| Jensen Alpha | 0.1013 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0087 | |||
| Treynor Ratio | 0.5324 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom Inc Backtested Returns
DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.0993, which denotes the company had a 0.0993% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Downside Deviation of 1.61, mean deviation of 1.54, and Coefficient Of Variation of 1497.13 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DexCom holds a performance score of 7. The firm shows a Beta (market volatility) of 0.24, which means not very significant fluctuations relative to the market. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether DexCom's price patterns will revert.
Auto-correlation | 0.37 |
Below average predictability
DexCom Inc has below average predictability. Overlapping area represents the amount of predictability between DexCom time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of 0.37 indicates that just about 37.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 3.6 |
DexCom Inc lagged returns against current returns
Autocorrelation, which is DexCom stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DexCom's stock expected returns. We can calculate the autocorrelation of DexCom returns to help us make a trade decision. For example, suppose you find that DexCom has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DexCom regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DexCom stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DexCom stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DexCom stock over time.
Current vs Lagged Prices |
| Timeline |
DexCom Lagged Returns
When evaluating DexCom's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DexCom stock have on its future price. DexCom autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DexCom autocorrelation shows the relationship between DexCom stock current value and its past values and can show if there is a momentum factor associated with investing in DexCom Inc.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.